DrHugh McCarthy

BSc, MBBS, MRCPCH, PhD, FRACP

I am a Clinical Academic and Paediatric Nephrologist based within the The Children's Hospital at Westmead Clinical School. My research focus is into the genomic determinants of kidney disease and the molecular basis of podocytopathies. I trained in the UK and completed my PhD at the University of Bristol, under the supervision of Professor Moin Saleem. In Australia, I am a founding member of the KIDGEN initiative - a national multidisciplinary collaborative studying the aetiology and management of genetic kidney disease. I co-designed the first diagnostic Australian Renal Gene Panel service, confering direct benefit to over 800 Australian renal patients from genomic advances in the field. In my clinical role, I developed and continue to run the NSW/ACT paediatric renal genetic clinical service. I work directly with patient advocacy groups in Australia to ensure consumer engagement. I supervise PhD, Honour and MD research project students within the Centre for Kidney Research, Westmead and am currently supervising projects including: Co-development of the Renal Genetic Clinical Service; Deciphering the aetiology of non-Mendelian nephrotic syndrome; novel gene discovery in renal disease. I am CIC on the MRFF funded OPEN study of prednisolone dosing in relapses of childhood steroid sensitive nephrotic syndrome and am the Clinical Lead for the Nacuity sponsered national Phase 2 trial in Cystinosis. I will be the principle investigator for the international EMPA-KIDS trial of Empagliflozin in Children with CKD sponsered by Boehringer Ingeilheim.